1 pending office actions • 0 art units • 1 examiners • 0 of 1 (0%) have an AI response strategy ready • 1 patents granted in the last 365 days
Tx Medic AB has 1 pending office action currently active. This single action is being handled by 1 distinct examiner, reflecting a concentrated prosecution focus for the company's patent portfolio. The data shows 0 distinct art units associated with this pending matter, which points to a specific administrative footprint for the current workload.
BERRY, LAYLA D is identified as the busiest examiner for the organization, with 1 busiest examiner pending action. This examiner is responsible for the entirety of the company's active office action volume. For practitioners, this means that the immediate success of the portfolio depends on the interaction with this 1 examiner. The alignment of 1 pending action with 1 distinct examiner suggests a very direct and uncomplicated prosecution landscape. This focus allows for a dedicated response strategy tailored to the specific examiner's feedback.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| Double-patenting + other | 1 (100%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| BERRY, LAYLA D | 1 | 66.0% | +9.0% |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18781181 | USE OF DEXTRAN SULFATE | BERRY, LAYLA D | — | §103DP | Non-Final OA | — | Pending | Jul 23, 2024 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial